IGFBP1 and hydrops fetalis: In HF with reduced ejection fraction (n = 537, 58–76 y, 26% F), IGFBP-1 was part of an optimal set of biomarkers identified as useful in the prediction of adverse clinical events over a median of 2.2 years [77].